[1]
T. Wiatr and P. Chłosta, “Mirabegron add-on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms”, J EBM, vol. 14, no. 1(50), pp. 58-62, Mar. 2021.